Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-19

Clinical Trial Update: Extended-release Pharmacotherapy for Opioid Use Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for an extended-release pharmacotherapy aimed at opioid use disorder, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Extended-release pharmacotherapy for opioid use disorder

Snippet

Sponsor: King's College London | Conditions: Opiate Substitution Treatment | Phase 3 | Status: COMPLETED